B4GALT1-Congenital Disorders of Glycosylation Presents as a Non-Neurologic Glycosylation Disorder with Hepatointestinal Involvement
Maïlys Guillard(Radboud University Nijmegen), Dirk J. Lefeber(Radboud University Nijmegen), Tony Roscioli(New South Wales Department of Health), Ron A. Wevers(Radboud University Nijmegen), Jorg C. de Ruijter(Radboud University Nijmegen), Éva Morava(Institut thématique Génétique, génomique et bioinformatique), Johann Penzien(University Hospital Augsburg), Olaf A. Bodamer(Broad Institute), Michèl A.A.P. Willemsen(Radboud University Nijmegen), Lambert van den Heuvel(Radboud University Nijmegen), Arjan de Brouwer(Radboud University Nijmegen)
Cited by 29
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326
SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder
|Cell|2010|315
Smith-Lemli-Opitz Syndrome Is Caused by Mutations in the 7-Dehydrocholesterol Reductase Gene
|The American Journal of Human Genetics|1998|297